AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 17-A-03-051.03
We recommend that the State agency ensure that MCOs submit drug utilization data containing NDCs for all physician-administered drugs.
The recommendation, in the publisher's words
We recommend that the State agency ensure that MCOs submit drug utilization data containing NDCs for all physician-administered drugs.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- December 30, 2016
- Report
- Delaware Did Not Bill Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations (A-03-15-00202) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- February 9, 2022 (publisher's date)
- Publisher topics
- Managed Care, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
1 more, of which 0 are open in the publisher's file.
- We recommend that the State agency work with CMS to resolve the drug utilization without valid NDCs for which we were not able to determine an estimate by determining the correct NDCs and…HHS OIG 17-A-03-051.01 · issued Dec 30, 2016 · closed Feb 9, 2022Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.